194 related articles for article (PubMed ID: 25984840)
1. Design, synthesis and antitumor activity of triterpenoid pyrazine derivatives from 23-hydroxybetulinic acid.
Zhang H; Wang Y; Zhu P; Liu J; Xu S; Yao H; Jiang J; Ye W; Wu X; Xu J
Eur J Med Chem; 2015 Jun; 97():235-44. PubMed ID: 25984840
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives.
Zhang H; Zhu P; Liu J; Yang X; Xu S; Yao H; Jiang J; Ye W; Wu X; Xu J
Eur J Med Chem; 2014 Nov; 87():159-67. PubMed ID: 25247772
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives.
Zhang H; Zhu P; Liu J; Lin Y; Yao H; Jiang J; Ye W; Wu X; Xu J
Bioorg Med Chem Lett; 2015 Feb; 25(3):728-32. PubMed ID: 25529742
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of Oxygen-containing Heterocyclic Ring-fused 23-Hydroxybetulinic Acid Derivatives as Antitumor Agents.
Zhang H; Li F; Zhu P; Liu J; Yao H; Jiang J; Ye W; Wu X; Xu J
Chem Biol Drug Des; 2015 Oct; 86(4):424-31. PubMed ID: 25688519
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and mechanism studies of C-23 modified 23-hydroxybetulinic acid derivatives as anticancer agents.
Lu L; Zhang H; Liu J; Liu Y; Wang Y; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2019 Nov; 182():111659. PubMed ID: 31491611
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines.
Kamal A; Ramakrishna G; Raju P; Rao AV; Viswanath A; Nayak VL; Ramakrishna S
Eur J Med Chem; 2011 Jun; 46(6):2427-35. PubMed ID: 21481986
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and mechanism studies of C-3 substituted nitrogenous heterocyclic 23-Hydroxybetulinic acid derivatives as anticancer agents.
Zhou H; Zhu H; Zha Y; Xu J; Wang T; Xu S
Fitoterapia; 2022 Jul; 160():105222. PubMed ID: 35618147
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells.
Shiokawa Z; Hashimoto K; Saito B; Oguro Y; Sumi H; Yabuki M; Yoshimatsu M; Kosugi Y; Debori Y; Morishita N; Dougan DR; Snell GP; Yoshida S; Ishikawa T
Bioorg Med Chem; 2013 Dec; 21(24):7938-54. PubMed ID: 24169315
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of 28-amide derivatives of 23-hydroxy betulinic Acid as antitumor agent candidates.
Bi Y; Xu J; Sun F; Wu X; Ye W; Sun Y; Huang W
Med Chem; 2013 Nov; 9(7):920-5. PubMed ID: 23083117
[TBL] [Abstract][Full Text] [Related]
14. Novel (S)-1,3,4,12a-tetrahydropyrazino[2,1-c][1,4]benzodiazepine-6,12(2H,11H)-dione derivatives: Selective inhibition of MV-4-11 biphenotypic B myelomonocytic leukemia cells' growth is accompanied by reactive oxygen species overproduction and apoptosis.
Mieczkowski A; Psurski M; Bagiński M; Bieszczad B; Mroczkowska M; Wilczek M; Czajkowska J; Trzybiński D; Woźniak K; Wietrzyk J
Bioorg Med Chem Lett; 2018 Feb; 28(4):618-625. PubMed ID: 29395971
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preliminary mechanistic evaluation of 5-(p-tolyl)-1-(quinolin-2-yl)pyrazole-3-carboxylic acid amides with potent antiproliferative activity on human cancer cell lines.
Cankara Pirol Ş; Çalışkan B; Durmaz I; Atalay R; Banoglu E
Eur J Med Chem; 2014 Nov; 87():140-9. PubMed ID: 25247770
[TBL] [Abstract][Full Text] [Related]
16. A Series of New Ligustrazine-Triterpenes Derivatives as Anti-Tumor Agents: Design, Synthesis, and Biological Evaluation.
Xu B; Chu F; Zhang Y; Wang X; Li Q; Liu W; Xu X; Xing Y; Chen J; Wang P; Lei H
Int J Mol Sci; 2015 Sep; 16(9):21035-55. PubMed ID: 26404253
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line.
Liu WK; Ho JC; Cheung FW; Liu BP; Ye WC; Che CT
Eur J Pharmacol; 2004 Sep; 498(1-3):71-8. PubMed ID: 15363977
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of ligustrazine - betulin amino-acid/dipeptide derivatives as anti-tumor agents.
Guo WB; Zhang H; Yan WQ; Liu YM; Zhou F; Cai DS; Zhang WX; Huang XM; Jia XH; Chen HS; Qi JC; Wang PL; Xu B; Lei HM
Eur J Med Chem; 2020 Jan; 185():111839. PubMed ID: 31708185
[TBL] [Abstract][Full Text] [Related]
19. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of Two Series of Novel A-Ring Fused Steroidal Pyrazines as Potential Anticancer Agents.
Wang S; Yuan X; Qian H; Li N; Wang J
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
